期刊文献+

基于体外试验评价透明质酸眼刺激保护作用

In vitro study on the protective effects of hyaluronic acid on eye irritation
下载PDF
导出
摘要 通过荧光素渗漏试验和重组人角膜上皮-眼刺激(ET_(50))试验,研究了高分子、低分子、酶切寡聚三种不同分子量的透明质酸对眼刺激的保护作用。参照OCED TG460选择七种物质在本实验室验证荧光素渗漏试验;并进一步采用荧光素渗漏试验和重组人角膜上皮-眼刺激(ET_(50))试验评价了三种透明质酸对荧光素钠渗漏率、细胞存活率等的影响,得到了透明质酸对眼刺激的保护作用体外评价结果。荧光素渗漏试验证实,10 g/L透明质酸能显著抑制0.25 g/L苯扎溴铵造成的MDCK细胞荧光素渗漏率增加;重组人角膜上皮-眼刺激试验证实,20 g/L酶切寡聚透明质酸能显著抑制乙酸甲酯造成的细胞存活率降低;重组人角膜上皮-眼刺激(ET_(50))试验证实,10 g/L透明质酸能显著抑制0.5 g/L苯扎溴铵造成的组织模型细胞存活率降低,增加ET_(50)值。结果表明,三种透明质酸均具有眼刺激性保护作用,揭示了透明质酸在化妆品应用的新前景,同时也为透明质酸眼刺激舒缓功效的评价开发了新方法。 Fluorescein leakage(FL)test and recombinant human corneal epithelial cell model eye stimulation(ET_(50))test were both took to investigate the protective effects of three different molecular weight hyaluronic acids(HA)including high,low and oligomeric on eye irritation.Firstly,seven verification substances in different stimulation levels including benzalkonium chloride(5%),4-carboxy-benzaldehyde,promethazine hydrochloride,ethyl-2-methylaceto-acetate,glycerol,sodium lauryl sulfate(15%,w/%)and sodium hydroxide(10%,w/%)were used to verify the luciferin leakage test in our own laboratory.Then,fluorescein leakage test and in vitro artificial cornea model-eye stimulation ET_(50)test were both conducted to evaluate the inhibitory effect of three hyaluronic acids on eye irritation by the index of fluorescence leakage rate as well as cell survival rate.Fluorescein leakage test method is established successfully and is confirmed that 10 g/L mass concentration of hyaluronic acid can significantly reduce the increase of fluorescence leakage rate caused by 0.25 g/L mass concentration of benzalkonium bromide.What’s more,incubating for another 24 h after exposure to 10 g/L mass concentration of hyaluronic acid and 0.25 g/L mass concentration of benzalkonium bromide for 30 min,the cell survival rate does not change,but the morphological change of the cells can be observed tending to be normal under the microscope,compared to the cells treated by 0.25 g/L mass concentration of benzalkonium bromide only.Meanwhile,in vitro artificial corneal model-eye stimulation test confirms that oligo hyaluronic acid can significantly inhibit the decrease of cell survival rate which causes by methyl acetate at mass concentration of20 g/L rather than 10 g/L.Accordingly,in vitro artificial corneal model-eye stimulation test(ET_(50))confirms that 10 g/L mass concentration of hyaluronic acid can significantly inhibit the decrease of cell survival rate and increase the ET_(50)value which is induced by 0.5 g/L mass concentration of benzalkonium bromide,but it falls flat on serious irritation induced by10%(w/%)content of Brij35 solution.In conclusion,these results show that high,low and oligomeric molecular weight hyaluronic acid can all significantly reduce the irritation of ocular stimulation induced by mild positive substances,which provides a basis for the protective effect of hyaluronic acid,reveals a new prospect of the application of hyaluronic acid in cosmetics and presents a new method of efficacy evaluation on cosmetic raw materials.
作者 耿雪 苏昕宇 张艳美 黄思玲 赵锷 祝清芬 Xue Geng;Xinyu Su;Yanmei Zhang;Siling Huang;E Zhao;Qingfen Zhu(NMPA Key Laboratory for Quality Control of Cosmetics Raw Material,Shandong Institute for Food and Drug Control,Jinan,Shandong 250101,China;Bloomage Biotech Corporation,Jinan,Shandong 251011,China;Shanghai Epskin Corporation,Shanghai 201206,China)
出处 《日用化学工业》 CAS 北大核心 2022年第4期404-409,共6页 China Surfactant Detergent & Cosmetics
关键词 眼刺激 透明质酸 眼刺激试验 重组人角膜上皮 荧光素渗漏试验 eye irritation hyaluronic acid eye irritation test recombinant human corneal epithelium fluorescein leakage
  • 相关文献

参考文献5

二级参考文献23

  • 1李家斌,赵凤培.硫酸妥布霉素治疗急性细菌性痢疾[J].中国抗生素杂志,1997,22(2):159-160. 被引量:7
  • 2MICHAELBALLS.3R和仁慈准则[M].程树军,译北京:科学出版社,2010.
  • 3KREWSKI D, ACOSTA D, ANDERSEN M, et al. Toxicity testing in the 21st century: a vision and a strategy[J]. Toxicol Environ Health B Crit Rev, 2010, 13: 51-138.
  • 4Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the Protection of Animals Used for Scientific Purposes[K]. Off J Eur Communities, 2010, L276: 33-79.
  • 5MOORE NP, ANDREW DJ, BJERKE DL, et al. Can acute dermal systemic toxicity tests be replaced with oral tests? A comparison of route-specific systemic toxicity and hazard classifications under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) [J]. Regulatory Toxicology and Pharmacology, 2013, 66(1): 30-37.
  • 6SEIDLE T, PRIETO P, BULGHERONI A. Examining the regulatory value of multi-route mammalian acute systemic toxicity studies[J]. Alternatives to Animal Experimentation, 2011, 28(2): 95-102.
  • 7ROBINSON S, DELONGEAS JL, DONALD E, et al. European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical drug development[J]. Regul Toxicol Pharmacol, 2008, 50: 345-352.
  • 8EURL ECVAM status report on the development, validation and regulatory acceptance of alternative methods and approaches[R]. JRC Science and Policy Report, 2015.
  • 9OECD. The Adverse outcome pathway for skin sensitisation initiated by covalent binding to proteins, part 2: use of the AOP to develop chemical categories and integrated assessment and testing approaches[K]. Series on Testing and Assessment No. 168, 2012.
  • 10RAMIREZ T, MEHLING A, KOLLE SN, et al. LuSens: a keratinocyte based ARE reporter gene assay for use in integrated testing strategies for skin sensitization hazard identification [J]. Toxicol In Vitro, 2014, 28(8): 1482-97.

共引文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部